Table 2 HBsAg prevalence of acute and chronic liver disease patients in different regions of Ethiopia from 1984 to 2013
From: Hepatitis viruses in Ethiopia: a systematic review and meta-analysis
Sampling year | Study area | Study design | Study Population | HBsAg, n (%) | Patients’ characterization and evaluation systema | References |
|---|---|---|---|---|---|---|
1984 | A.Ababa | Prospective longitudinal | 304 | 30(9.9) | Patients with acute or chronic hepatitis, some with malignant liver disease, mainly hepatocellular carcinoma (HCC) | [45] |
1989 | A.Ababa | Consecutive hospital patients | 334 | 91(27.2) | Based on clinical and histological diagnostic criteria; patients with chronic hepatitis (n = 114), cirrhosis (n = 208) and hepatocellular carcinoma (n = 112) | [46] |
1991 | North Ethiopia | Epidemic outbreak | 423 | 54(12.8) | Icteric patients hospitalized during HEV | [47] |
1992 | A.Ababa | Consecutive hospital patients | 110 | 22(20.0) | Consecutive acute hepatitis patients and 19 pregnant women who had HEV infection | [48] |
1995 | A.Ababa | Consecutive hospital patients | 238 | 65(27.3) | Patients with chronic hepatitis (n = 14), cirrhotic (n = 156) and HCC (n = 68) | [49] |
2011 | A.Ababa | Prospective consecutive hospital patients | 120 | 43(35.8) | Patients with chronic liver disease based on clinical history, ultrasound, and impaired liver function tests. | [44] |
2011 | Gondar | Retrospective | 2684 | 386(14.4) | Five year retrospective study on clinically suspected hepatitis patients from different wards of Gondar hospital | [50] |
2013 | Bale Robe | Retrospective | 358 | 80(22.3) | All patients with chronic hepatitis | [51] |